Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 3b (C3b) is a central effector molecule in the complement system, a key part of innate immunity. It is generated by the proteolytic cleavage of complement component 3 (C3) and plays a critical role in opsonization, tagging pathogens and immune complexes for phagocytosis. C3b also participates in the formation of C3 and C5 convertases, amplifying the complement cascade. Its ability to covalently attach to microbial surfaces via its exposed thioester bond allows it to efficiently mark targets for immune clearance. Regulation of C3b activity is crucial to prevent damage to host tissues, and deficiencies in regulation can lead to autoimmune diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component 3b (C3b).